Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan

PURPOSE: Bevacizumab (BEV) has been used for ovarian cancer (OC) for years in Taiwan, but the associated data related to outcome is scant. This retrospective study reviewed patients with OC treated with BEV and analyzed their results. PATIENTS AND METHODS: All patients with OC treated with BEV from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Chen, Wei-Chun, Qiu, Jiantai Timothy, Lai, Chyong-Huey, Huang, Huei-Jean, Lin, Cheng-Tao, Chen, Min-Yu, Chou, Hung-Hsueh, Huang, Kuan-Gen, Chang, Ting-Chang
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5415172/
https://ncbi.nlm.nih.gov/pubmed/28467466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0175703
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados